Pharmaceuticals Policy and Law - Volume 9, issue 1-2
Purchase individual online access for 1 year to this journal.
Price: EUR 100.00
The new international review,
Pharmaceuticals Policy and Law, appears with the aim of studying and evaluating the
legal status of medicinal products in the European Union, and its implications in other markets such as the USA and Japan, without neglecting the specific problems of developing countries.
Pharmaceuticals Policy and Law intends to participate in the process of world convergence of pharmaceutical legislation helped by a network of academic centers specializing in pharmaceutical law, without omitting a scientific, economic and social approach to medicinal products.
The specificity of medicinal products conditions their legal status. Legislation regulating other goods cannot be applied to them. To begin with, they are the result of scientific and technical innovation. Research policies determine their progress. The pharmaceutical industry is, by nature, multinational. But, next to these global trends, different traditions still remain at a national level. Within the EU, barriers to free trade in medicinal products still remain despite more than thirty years of harmonisation. The social dimension of medicinal products is complex and very significant in the preoccupations of our societies. Patenting is essential but not sufficient. The life-cycle of medicinal products is protected by professional responsibility, required in the general concept of health safety. It is important to remember their ethical dimension, including research and innovation in new fields such as genetic manipulation and biotechnology, which requires social consent to preserve human dignity and fundamental rights.
Abstract: There is growing concern about a decline in the total fertility rate worldwide, but nowhere is the concern greater than in OECD countries, some of which already face the prospect of population decline as well. While the trend is largely the result of structural economic and social changes, our paper indicates that it is partly influenced by the scale of the defined-benefits, pay-as-you-go (PAYG) social security systems operating in most countries. Through a dynamic, overlapping-generations model…where the generations are linked by parental altruism, we show analytically that social security tax and benefit rates generate incentives for individuals to reduce not just the fertility rate within families, but also the incentive to form families, which we capture empirically by the fraction of adults married. We conduct calibrated simulations as well as regression analyses that measure the quantitative importance of social security tax rates in lowering both net marriage and total fertility rates. Our results show that the impact of social security on these variables has been non-trivial. We also offer policy implications concerning the desirable way to reform the current social security system in order to mitigate its unintended effects on family formation and fertility and improve its financial solvency.
Abstract: While some are proponents of restrictive legislation, others have argued that there is too much legislation for ART and cite existing legal choices for women in relation to human reproduction which respect individual autonomy. It has been argued that where genuine, informed decision-making occurs and there is a process for legitimate ethical review, that restrictive laws make little sense. In some cases restrictive legislation denies access to appropriate treatment for couples that have no other means…of forming their families. History reveals that governments can make ill informed, expedient decisions, which are not necessarily in the best interests of their citizens. Italy provides a sobering example. Legislation is difficult to repeal and in a high-tech, rapidly evolving area such as ART, even the most well intended legislation could quickly prove obsolete. In Australia, crucial to achieving good outcomes in the regulation of ART has been the involvement of patients in legislation, accreditation and policy, working in partnership with health care providers, the media and members of parliament. This has ensured transparency and quality in service delivery. It is also appropriate, as it recognises that ultimately it is patients who must live with the consequences of policy and treatment decisions.
Abstract: Technological advances during the past decade have dramatically increased the success rates of ART. Unlike the leaps that technology has taken, the law and public policy have been slower to advance. The legal regulation of the techniques that help to overcome infertility problems are based on the fundamental rights of the persons. The freedom to procreate, as a premise to the right to form a family, is the realisation of the free development of personality and, inserts…itself in the scope of freedoms and not in that of rights, in a strict sense. We need to consider the meaning of human procreation in all its aspects and entailments. The law must address transcendent ethical worries. However, there must not be confusion between the ethical and legal dimensions. The article identifies and defines, the main problems which face the legislator and which the legal system must respond to. The areas which need regulation are the foundational value of human, the protection of human dignity, the health of the human subjects, human freedom, the intrinsic value of new knowledge, the promotion of justice and equality, privacy, without forgetting, the relief of the suffering of those afflicted with infertility. The regulation of informed consent is another essential element of the exercise of the assisted reproduction techniques. Legal systems must provide an adequate response to all of the above issues. Although there are some discrepancies between the legislation of different countries, there are also some significant similarities. The response in each country was conditioned by its cultural, religious and social traditions.
Abstract: The major complication of assisted reproductive technologies is the increased incidence of multiple pregnancies. Multiple pregnancies are associated with higher morbidity and mortality rates related to a higher incidence of prematurity and (very) low-birth-weight babies. The epidemic of iatrogenic multiple births has increased the incidence of maternal, perinatal and childhood morbidity and mortality. Healthcare cost of infertility treatment did increase significantly and this may lead to social and political concern. For in…vitro fertilization, reducing the number of embryos transferred and the use of natural cycle IVF will decrease the number of multiple gestations. For non-IVF ovarian stimulation, a strict ovarian stimulation protocol aiming at mono-ovulation should be followed. The Belgian project to prevent multiple pregnancies was started in July 2003. A reimbursement of ART-related laboratory activities was linked to a transfer policy aiming at substantial multiple pregnancy reduction. It's a nice example of efficient forward looking health economics through responsabilisation. The first results indicate an increase of the number of IVF cycles by more than 30% and a more than 50% reduction of twin pregnancies. The next step will be the prevention of multiple pregnancies associated with non-IVF ovarian stimulation.
Keywords: Access to treatment, infertility treatment, IVF, multiple pregnancies, policy